PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,602 stories, page 402 of 677

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Cracks Down On Mumbai Clubs For Food Safety Violations

rediff.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Alnylam’s stock is down 30% despite a booming biotech market. Here’s why

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Grants Fast Track Designation to HTX-001 for nHCM

HCPLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CHMP backs Roche’s Susvimo as first continuous nAMD therapy

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Peli BioThermal Partners with PAXAFE to Redefine Pharmaceutical Cold Chain Intelligence

PR NewswireOriginal source
🇺🇸Devicespathai.comTier 1 · Company source

PathAI Advances AISight® Dx with the v2.21 Release: Intelligent Dashboard Controls, Enhanced Data Organization, & Enterprise-Scale Configurability

PathAIOriginal source
🌍discoverynews.google.comTier 2 · Trade media

GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China’s biotech rise to face challenges from US policy responses

PharmaLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Brewing Up Biotech: Tea Catechins and Their Anti-Aging Impact

Cosmetics & ToiletriesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BrainStorm Appoints Former FDA Official Peter Pitts Executive Chairman to Lead Phase 3 ALS Strategy

citybizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Potential Retatrutide Benefits You Should Know About

GoodRxOriginal source
🇺🇸Research5amventures.comTier 2 · Direct publisher

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

5AM VenturesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Navigating Technology Transfer in Pharma and Biotech

Technology NetworksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edison issues report on BB Biotech (BION)

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

An eye drug biotech banks $118M and stocks its executive suite

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Stay Ahead of the Game With Teva Pharmaceutical Industries (TEVA) Q2 Earnings: Wall Street's Insights on Key Metrics

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amgen makes case to continue selling drug that FDA links to deaths

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves first over-the-counter Tylenol & Naproxen tab for 12-hour pain relief

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals (ASX:RCE) Advances Phase 3 Trials and MENA Licensing Strategy as Commercial Pathway Develops

KalkineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech names interim CEO after Ying Huang steps down

The Pharma LetterOriginal source
🇺🇸Devicesviz.aiTier 1 · Company source

A Decade of Increasing Access to Life Saving Treatments: Viz.ai Celebrates 10 Years, 2,000 Hospitals, and 230 Million Patients

Viz.aiOriginal source
🇺🇸CDMOagcbio.comTier 2 · Direct publisher

AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars

AGC BiologicsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Ad Urges Viewers To Fight Doctors Who Say Drug Not Right For Them

The OnionOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI in Pharmaceutical Manufacturing: Executive Handbook on AI Readiness, Digital Maturity and Factory Transformation

EIN PresswireOriginal source
🇺🇸Industryir.codexis.comTier 1 · Company source

Codexis to Report Second Quarter 2026 Financial Results on August 11

CodexisOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Suspends FSSAI Licence Of Fort's Poornima Restaurant Over Fungal Food and Hygiene Violations

lokmattimes.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Boston Scientific unveils major restructuring, plots job cuts amid savings drive

Fierce BiotechOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Botulism: clinical and public health management

Information for healthcare professionals on the diagnosis and treatment of infant botulism, foodborn...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees

The Motley FoolOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

4EU+ European University Alliance Goes into Third Funding Period

Heidelberg UniversityOriginal source
🌍Medianovartis.comTier 3 · Secondary coverage

Smarter decisions at scale: How Novartis is using AI to advance R&D

NovartisOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Bioscience and health technology sector statistics 2024 to 2025

Official statistics in development estimating the size and composition of the life sciences sector i...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EU governments set to address biotech and economic security

Research Professional NewsOriginal source
🌍Industryrelmada.comTier 1 · Company source

Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

Relmada TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chip Parkinson on Direct-to-Patient's Big Year

Pharmaceutical CommerceOriginal source
🇺🇰Industrygsk.comTier 1 · Company source

GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK

GSK NewsOriginal source
🇺🇸Devicesapyxmedical.comTier 1 · Company source

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

Apyx MedicalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Five-Gate Framework Proposed for India-UK Pharmaceutical Trade Agreement Implementation

geneonline.comOriginal source
🇺🇰Industrygsk.comTier 1 · Company source

GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026

GSK NewsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Oxygen 100%: Gas cylinders containing commercial grade oxygen

Gas cylinders containing industrial grade oxygen were delivered instead of medical grade oxygen.

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

IQecg® Digital ECG

Affected IQecg® plugin software may produce incorrect ECG waveforms and inaccurate heart-rate calcul...

Health Canada Recalls and Safety AlertsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A webcast will carry Legend Biotech's Q2 results review Aug. 11

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oak Hill Bio Announces Dosing of First Participant in

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trevi Therapeutics to present at August biotech conferences on its chronic cough therapy Haduvio™

PluangOriginal source
🌍Mediaheartsciences.comTier 2 · Direct publisher

Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio

HeartSciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jordanian Pharmaceutical Manufacturing Q2 Profit 1.9 Million Dinars

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'grady As Chief Executive Officer To Lead Strategic Growth

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GSK beats consensus forecast in second quarter

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Buy on Legend Biotech stock, $65 target

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA is Rubric Capital Management LP's 4th Largest Position

MarketBeatOriginal source
🇺🇰Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Tommy’s National Centre for Miscarriage Research celebrates ten years of progress

Oxford MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grace Therapeutics Says FDA Minutes Confirm No Clinical Safety or Efficacy Deficiencies in GTx-104 Review, Advances Dual-Source Manufacturing Plan Toward NDA Resubmission

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Atea Pharmaceuticals Reports Positive Phase 3 C-BEYOND Results for Bemnifosbuvir/Ruzasvir in Hepatitis C, Achieving Non-Inferiority to Epclusa

Quiver QuantitativeOriginal source
🇺🇰Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

Oxford MedicineOriginal source